116 related articles for article (PubMed ID: 20197379)
1. 3-phosphoinositide-dependent protein kinase-1 regulates proliferation and survival of cancer cells with an activated mitogen-activated protein kinase pathway.
Lu Z; Cox-Hipkin MA; Windsor WT; Boyapati A
Mol Cancer Res; 2010 Mar; 8(3):421-32. PubMed ID: 20197379
[TBL] [Abstract][Full Text] [Related]
2. Indomethacin induces apoptosis in 786-O renal cell carcinoma cells by activating mitogen-activated protein kinases and AKT.
Ou YC; Yang CR; Cheng CL; Raung SL; Hung YY; Chen CJ
Eur J Pharmacol; 2007 Jun; 563(1-3):49-60. PubMed ID: 17341418
[TBL] [Abstract][Full Text] [Related]
3. Notch1 signaling promotes primary melanoma progression by activating mitogen-activated protein kinase/phosphatidylinositol 3-kinase-Akt pathways and up-regulating N-cadherin expression.
Liu ZJ; Xiao M; Balint K; Smalley KS; Brafford P; Qiu R; Pinnix CC; Li X; Herlyn M
Cancer Res; 2006 Apr; 66(8):4182-90. PubMed ID: 16618740
[TBL] [Abstract][Full Text] [Related]
4. Transforming growth factor beta induces apoptosis through repressing the phosphoinositide 3-kinase/AKT/survivin pathway in colon cancer cells.
Wang J; Yang L; Yang J; Kuropatwinski K; Wang W; Liu XQ; Hauser J; Brattain MG
Cancer Res; 2008 May; 68(9):3152-60. PubMed ID: 18451140
[TBL] [Abstract][Full Text] [Related]
5. Serine-arginine protein kinase 1 overexpression is associated with tumorigenic imbalance in mitogen-activated protein kinase pathways in breast, colonic, and pancreatic carcinomas.
Hayes GM; Carrigan PE; Miller LJ
Cancer Res; 2007 Mar; 67(5):2072-80. PubMed ID: 17332336
[TBL] [Abstract][Full Text] [Related]
6. Down-regulation of mcl-1 by small interfering RNA sensitizes resistant melanoma cells to fas-mediated apoptosis.
Chetoui N; Sylla K; Gagnon-Houde JV; Alcaide-Loridan C; Charron D; Al-Daccak R; Aoudjit F
Mol Cancer Res; 2008 Jan; 6(1):42-52. PubMed ID: 18234961
[TBL] [Abstract][Full Text] [Related]
7. Potential inhibition of PDK1/Akt signaling by phenothiazines suppresses cancer cell proliferation and survival.
Choi JH; Yang YR; Lee SK; Kim SH; Kim YH; Cha JY; Oh SW; Ha JR; Ryu SH; Suh PG
Ann N Y Acad Sci; 2008 Sep; 1138():393-403. PubMed ID: 18837915
[TBL] [Abstract][Full Text] [Related]
8. Expression of the SNT-1/FRS2 phosphotyrosine binding domain inhibits activation of MAP kinase and PI3-kinase pathways and antiestrogen resistant growth induced by FGF-1 in human breast carcinoma cells.
Manuvakhova M; Thottassery JV; Hays S; Qu Z; Rentz SS; Westbrook L; Kern FG
Oncogene; 2006 Sep; 25(44):6003-14. PubMed ID: 16682955
[TBL] [Abstract][Full Text] [Related]
9. IGF-1 activates hEAG K(+) channels through an Akt-dependent signaling pathway in breast cancer cells: role in cell proliferation.
Borowiec AS; Hague F; Harir N; Guénin S; Guerineau F; Gouilleux F; Roudbaraki M; Lassoued K; Ouadid-Ahidouch H
J Cell Physiol; 2007 Sep; 212(3):690-701. PubMed ID: 17520698
[TBL] [Abstract][Full Text] [Related]
10. Down-regulation of 3-phosphoinositide-dependent protein kinase-1 levels inhibits migration and experimental metastasis of human breast cancer cells.
Liu Y; Wang J; Wu M; Wan W; Sun R; Yang D; Sun X; Ma D; Ying G; Zhang N
Mol Cancer Res; 2009 Jun; 7(6):944-54. PubMed ID: 19531564
[TBL] [Abstract][Full Text] [Related]
11. Light at night activates IGF-1R/PDK1 signaling and accelerates tumor growth in human breast cancer xenografts.
Wu J; Dauchy RT; Tirrell PC; Wu SS; Lynch DT; Jitawatanarat P; Burrington CM; Dauchy EM; Blask DE; Greene MW
Cancer Res; 2011 Apr; 71(7):2622-31. PubMed ID: 21310824
[TBL] [Abstract][Full Text] [Related]
12. Functional and therapeutic significance of Akt deregulation in malignant melanoma.
Robertson GP
Cancer Metastasis Rev; 2005 Jun; 24(2):273-85. PubMed ID: 15986137
[TBL] [Abstract][Full Text] [Related]
13. Silencing SOX2 Expression by RNA Interference Inhibits Proliferation, Invasion and Metastasis, and Induces Apoptosis through MAP4K4/JNK Signaling Pathway in Human Laryngeal Cancer TU212 Cells.
Yang N; Wang Y; Hui L; Li X; Jiang X
J Histochem Cytochem; 2015 Sep; 63(9):721-33. PubMed ID: 26001828
[TBL] [Abstract][Full Text] [Related]
14. AURKA is one of the downstream targets of MAPK1/ERK2 in pancreatic cancer.
Furukawa T; Kanai N; Shiwaku HO; Soga N; Uehara A; Horii A
Oncogene; 2006 Aug; 25(35):4831-9. PubMed ID: 16532023
[TBL] [Abstract][Full Text] [Related]
15. Down-regulation of the tumor suppressor gene C-terminal Src kinase: an early event during premalignant colonic epithelial hyperproliferation.
Kunte DP; Wali RK; Koetsier JL; Hart J; Kostjukova MN; Kilimnik AY; Pyatkin IG; Strelnikova SR; Roy HK
FEBS Lett; 2005 Jul; 579(17):3497-502. PubMed ID: 15961079
[TBL] [Abstract][Full Text] [Related]
16. PDK1 controls upstream PI3K expression and PIP3 generation.
Dieterle AM; Böhler P; Keppeler H; Alers S; Berleth N; Drießen S; Hieke N; Pietkiewicz S; Löffler AS; Peter C; Gray A; Leslie NR; Shinohara H; Kurosaki T; Engelke M; Wienands J; Bonin M; Wesselborg S; Stork B
Oncogene; 2014 Jun; 33(23):3043-53. PubMed ID: 23893244
[TBL] [Abstract][Full Text] [Related]
17. The deacetylase SIRT1 promotes membrane localization and activation of Akt and PDK1 during tumorigenesis and cardiac hypertrophy.
Sundaresan NR; Pillai VB; Wolfgeher D; Samant S; Vasudevan P; Parekh V; Raghuraman H; Cunningham JM; Gupta M; Gupta MP
Sci Signal; 2011 Jul; 4(182):ra46. PubMed ID: 21775285
[TBL] [Abstract][Full Text] [Related]
18. Selective 3-phosphoinositide-dependent kinase 1 (PDK1) inhibitors: dissecting the function and pharmacology of PDK1.
Medina JR
J Med Chem; 2013 Apr; 56(7):2726-37. PubMed ID: 23448267
[TBL] [Abstract][Full Text] [Related]
19. Upregulation of MAPK/Erk and PI3K/Akt pathways in ulcerative colitis-associated colon cancer.
Setia S; Nehru B; Sanyal SN
Biomed Pharmacother; 2014 Oct; 68(8):1023-9. PubMed ID: 25443414
[TBL] [Abstract][Full Text] [Related]
20. 3-Phosphoinositide-dependent kinase 1 potentiates upstream lesions on the phosphatidylinositol 3-kinase pathway in breast carcinoma.
Maurer M; Su T; Saal LH; Koujak S; Hopkins BD; Barkley CR; Wu J; Nandula S; Dutta B; Xie Y; Chin YR; Kim DI; Ferris JS; Gruvberger-Saal SK; Laakso M; Wang X; Memeo L; Rojtman A; Matos T; Yu JS; Cordon-Cardo C; Isola J; Terry MB; Toker A; Mills GB; Zhao JJ; Murty VV; Hibshoosh H; Parsons R
Cancer Res; 2009 Aug; 69(15):6299-306. PubMed ID: 19602588
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
